Mike Kowalski
Biography
Overview
Mike is an associate at White & Case in New York. His practice focuses primarily on the representation of major commercial banks, investment banks, private equity sponsors, funds, and corporate borrowers in connection with secured and unsecured syndicated credit facilities and leveraged acquisition financings that are both global and domestic in nature.
He previously lived in London, United Kingdom, where he studied cross-border deals and developed valued relationships with professionals at London-based law firms and the Bank of England.
Experience
Representation of Deutsche Bank AG New York Branch, as sole lead arranger and lender, in connection with a Senior Debtor-In-Possession (DIP) credit facility provided to certain subsidiaries of Hornblower Holdings LP in connection with their commencement of Chapter 11 proceedings in the US Bankruptcy Court. The senior DIP financing consisted of a US$ 300 million term loan, with the proceeds thereof used to refinance certain existing debt, to pay fees and expenses and for working capital purposes. Hornblower is a multi-national operator of ferries and cruises and provider of travel experiences.
Representation of Oaktree Capital Management LP as Lender (with Oaktree Fund Administration LLC as the Administrative Agent and Collateral Agent) in connection with US$50 million second lien credit facility provided to Pinstripes, Inc, a dining and entertainment brand providing bistro, bowling, bocce and private event spaces. Pinstripes went public concurrently with the closing through a business combination agreement with Banyan Acquisition Corporation, which changed its name to Pinstripes Holdings, Inc. upon consummation of the transaction. Proceeds from the term loans were used for general corporate purposes and to fund the transactions.
Representation of Ares Capital Corporation as Administrative Agent and Lender, and its various funds as Lenders in connection with an unsecured term loan facility. The financing involved an unsecured US$250 million term loan facility, used to make closing date repayments, provide liquidity for near-term obligations, finance the Transactions and for general corporate purposes, and US$75 million delayed draw term loan facility, used for acquisitions, de novo growth capital expenditures and to repay revolving loans or replenish cash on hand. The Borrower, AmeriVet Partners Management, Inc., is a leading veterinary services platform with approximately 140 animal hospitals across more than 30 states, making it the tenth largest platform in the United States.
Representation of J.P. Morgan Securities LLC and Leerink Partners LLC as the representatives of the underwriters on the approximately US$100 million follow-on offering of 20,000,000 ordinary shares of common stock of Wave Life Sciences Ltd., a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases.
